214 related articles for article (PubMed ID: 15750929)
1. Profile of neuroblastoma detected by mass screening, resected after observation without treatment: results of the Wait and See pilot study.
Oue T; Inoue M; Yoneda A; Kubota A; Okuyama H; Kawahara H; Nishikawa M; Nakayama M; Kawa K
J Pediatr Surg; 2005 Feb; 40(2):359-63. PubMed ID: 15750929
[TBL] [Abstract][Full Text] [Related]
2. Observation of untreated patients with neuroblastoma detected by mass screening: a "wait and see" pilot study.
Yoneda A; Oue T; Imura K; Inoue M; Yagi K; Kawa K; Nishikawa M; Morimoto S; Nakayama M
Med Pediatr Oncol; 2001 Jan; 36(1):160-2. PubMed ID: 11464874
[TBL] [Abstract][Full Text] [Related]
3. Outcome of infants with neuroblastoma detected by mass screening and surgically treated in Shiga Prefecture, Japan: what is the role of surgery?
Hase T; Ohta S; Tani T; Mizukuro T; Mekata E; Naitoh H; Shimadera S; Fujino S; Taga T
Pediatr Surg Int; 2002 Sep; 18(5-6):289-94. PubMed ID: 12415341
[TBL] [Abstract][Full Text] [Related]
4. Neuroblastoma detected by mass screening: the Tumor Board's role in its treatment.
Okazaki T; Kohno S; Mimaya J; Hasegawa S; Urushihara N; Yoshida A; Kawano S; Kusafuka J; Horikoshi Y; Takashima Y; Aoki K; Hamazaki M
Pediatr Surg Int; 2004 Jan; 20(1):27-32. PubMed ID: 14689211
[TBL] [Abstract][Full Text] [Related]
5. A prospective study of a long-term follow-up of an observation program for neuroblastoma detected by mass screening.
Tanaka M; Kigasawa H; Kato K; Ijiri R; Nishihira H; Aida N; Ohama Y; Tanaka Y
Pediatr Blood Cancer; 2010 Apr; 54(4):573-8. PubMed ID: 20049932
[TBL] [Abstract][Full Text] [Related]
6. Natural course of neuroblastoma detected by mass screening: s 5-year prospective study at a single institution.
Nishihira H; Toyoda Y; Tanaka Y; Ijiri R; Aida N; Takeuchi M; Ohnuma K; Kigasawa H; Kato K; Nishi T
J Clin Oncol; 2000 Aug; 18(16):3012-7. PubMed ID: 10944135
[TBL] [Abstract][Full Text] [Related]
7. Maturation of mass-screened localized adrenal neuroblastoma.
Iwanaka T; Yamamoto K; Ogawa Y; Arai M; Ito M; Kishimoto H; Hanada R; Imaizumi S
J Pediatr Surg; 2001 Nov; 36(11):1633-6. PubMed ID: 11685689
[TBL] [Abstract][Full Text] [Related]
8. Retroperitoneal ganglioneuroblastoma resected 8 years after mass screening: a case report.
Nakaoka T; Uemura S; Nakagawa Y; Yano T; Oda M
J Pediatr Surg; 2007 Nov; 42(11):E29-32. PubMed ID: 18022424
[TBL] [Abstract][Full Text] [Related]
9. Laparoscopic resection of an adrenal neuroblastoma detected by mass screening that grew in size during the observation period.
Komuro H; Makino S; Tahara K
Surg Endosc; 2000 Mar; 14(3):297. PubMed ID: 10854521
[TBL] [Abstract][Full Text] [Related]
10. Biological characteristics of neuroblastoma with partial deletion in the short arm of chromosome 1.
Hiyama E; Hiyama K; Ohtsu K; Yamaoka H; Fukuba I; Matsuura Y; Yokoyama T
Med Pediatr Oncol; 2001 Jan; 36(1):67-74. PubMed ID: 11464909
[TBL] [Abstract][Full Text] [Related]
11. Bilateral adrenal neuroblastoma.
Ishiguro Y; Iio K; Seo T; Nagaya M; Ito T
Eur J Pediatr Surg; 1994 Feb; 4(1):37-9. PubMed ID: 8199131
[TBL] [Abstract][Full Text] [Related]
12. Role of ultrasound in managing neuroblastoma detected by mass screening: a proposed ultrasonographic grading for children with neuroblastoma.
Hirata T; Tatara H; Zaizen Y; Suita S; Matsuzaki A; Ueda K
J Clin Ultrasound; 1995 Jun; 23(5):305-13. PubMed ID: 7642769
[TBL] [Abstract][Full Text] [Related]
13. Multifocal neuroblastoma: biologic behavior and surgical aspects.
Hiyama E; Yokoyama T; Hiyama K; Yamaoka H; Matsuura Y; Nishimura Si; Ueda K
Cancer; 2000 Apr; 88(8):1955-63. PubMed ID: 10760774
[TBL] [Abstract][Full Text] [Related]
14. Connatal localized neuroblastoma. The case to delay treatment.
Kerbl R; Urban CE; Lackner H; Höfler G; Ambros IM; Ratschek M; Ambros PF
Cancer; 1996 Apr; 77(7):1395-401. PubMed ID: 8608521
[TBL] [Abstract][Full Text] [Related]
15. Results for 79 patients with neuroblastoma detected through mass screening at 6 months of age in a single institute.
Nishio N; Mimaya J; Nara T; Takashima Y; Horikoshi Y; Urushihara N; Hasegawa S; Aoki K; Hamasaki M
Pediatr Int; 2006 Dec; 48(6):531-5. PubMed ID: 17168969
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up results of the observation program for neuroblastoma detected at 6-month mass screening.
Arakawa A; Oguma E; Aihara T; Kishimoto H; Kikuchi A; Hanada R; Koh K
J Pediatr; 2014 Oct; 165(4):855-7.e1. PubMed ID: 25091258
[TBL] [Abstract][Full Text] [Related]
17. Mass screening for neuroblastoma: quo vadis? A 9-year experience from the Pediatric Oncology Study Group of the Kyushu area in Japan.
Suita S; Zaizen Y; Sera Y; Takamatsu H; Mizote H; Ohgami H; Kurosaki N; Ueda K; Tasaka H; Miyazaki S; Sugimoto T; Kawakami K; Tsuneyoshi M; Yano H; Akiyama H; Ikeda K
J Pediatr Surg; 1996 Apr; 31(4):555-8. PubMed ID: 8801312
[TBL] [Abstract][Full Text] [Related]
18. A trial to discriminate spontaneous regression from non-regression cases during mass screening for neuroblastoma.
Nishi M; Miyake H; Takeda T; Yonemori H; Hanai J; Kikuchi Y; Takasugi N
Jpn J Clin Oncol; 1994 Oct; 24(5):247-51. PubMed ID: 7967103
[TBL] [Abstract][Full Text] [Related]
19. Treatment complications in children diagnosed with neuroblastoma during a screening program.
Barrette S; Bernstein ML; Leclerc JM; Champagne MA; Samson Y; Brossard J; Woods WG
J Clin Oncol; 2006 Apr; 24(10):1542-5. PubMed ID: 16575005
[TBL] [Abstract][Full Text] [Related]
20. Congenital stage 1 neuroblastoma evolved into stage 4s.
Schiavetti A; Foco M; Ingrosso A; Chiriacò D; Ballesio L
J Pediatr Hematol Oncol; 2009 Jan; 31(1):59-60. PubMed ID: 19125091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]